Dipak Kanayalal Shah Portfolio: 42 Stocks, Rs 176 Cr
Dipak Kanayalal Shah’s Portfolio: The Quick Numbers
Dipak Kanayalal Shah’s disclosed equity portfolio is worth Rs 176.14 crore, according to the latest Trendlyne Superstar Portfolio filing. The portfolio rose 42.31% from the previous quarter and is spread across 42 stocks, making it one of the more widely diversified individual portfolios in this data set.
With such a large stock count relative to the total portfolio size, this looks like a small and mid cap focused, stock-picking style of investing, where capital is spread thin across many names rather than concentrated in a handful of large bets.
Portfolio Snapshot
| Metric | Value |
|---|---|
| Portfolio value | Rs 176.14 crore |
| Quarterly change | +42.31% |
| Number of stocks | 42 |
| Top sector | Pharmaceuticals & Biotechnology (22.32%) |
| Second sector | Commercial Services & Supplies (17.66%) |
| Third sector | Consumer Durables (17.19%) |
Top Holdings
- Borosil, Rs 27.07 crore
- Kilitch Drugs India, Rs 21.27 crore
- Amrutanjan Health Care, Rs 18.05 crore
Even the largest holding, Borosil, makes up only about 15% of the total portfolio. That is a strong signal that no single stock is expected to carry the portfolio’s performance on its own.
Recent Buying and Selling Activity
This filing shows more buying than selling activity, and the moves are spread across smaller companies.
Recently bought:
– WEP Solutions, up 1.22 percentage points in weight
– Magnum Ventures, up 1.11 percentage points
– Inter State Oil Carrier, up 1.08 percentage points
Recently sold:
– Organic Coatings, down 0.52 percentage points
– Jaipan Industries, down 0.29 percentage points
The buying here outweighs the selling in percentage terms, and it lines up with the strong 42.31% rise in overall portfolio value this quarter. None of these individual moves are large enough to reshape the entire portfolio, which fits the pattern of a diversified, many-small-positions approach.
What the Sector Mix Tells Us
Pharmaceuticals and biotechnology lead the sector allocation at 22.32%, a sector that has long been a favorite among Indian value and small cap investors because of steady domestic demand and India’s position as a major global supplier of generic medicines.
Commercial services and supplies, at 17.66%, and consumer durables, at 17.19%, round out the top three. Together, these three sectors make up just over 57% of the portfolio, which leaves a substantial portion spread across other sectors not listed in the top three, reinforcing the diversified nature of this portfolio.
Borosil, the top holding, is a well known name in glassware and scientific and industrial glass products in India. Kilitch Drugs India operates in pharmaceutical manufacturing, while Amrutanjan Health Care is known for over-the-counter healthcare and pain relief products, a household name in parts of the country for decades.
How Superstar Portfolio Disclosures Work
This entire dataset exists because of a SEBI rule: once an individual investor’s stake in a listed company crosses 1% of its outstanding equity, the company must disclose that stake publicly in its shareholding pattern.
These disclosures happen quarterly, tied to each company’s regulatory filing cycle. Trendlyne and similar platforms then compile this scattered public information into a single, searchable view per investor, which is how portfolios like this one become visible.
A few limits worth remembering when reading this kind of data:
- Positions under 1% ownership in any company do not appear here, so the real number of stocks an investor holds could be higher.
- The filing is a quarterly snapshot, so it always lags real-time portfolio decisions by weeks or months.
- No entry price or purchase date is disclosed, only the relative change in weight from one quarter to the next.
- A 42.31% jump in portfolio value could come from stock price gains, fresh capital being added, or some mix of both. This data alone cannot separate the two.
What a 42 Stock Portfolio Signals About Risk
Spreading capital across 42 stocks significantly reduces the impact any single company’s bad news can have on total portfolio value. If one holding drops sharply due to weak earnings or sector headwinds, the overall damage to a portfolio this spread out is naturally limited.
The tradeoff is that broad diversification like this also means it takes a genuinely exceptional performance from several holdings at once to meaningfully move the whole portfolio’s value, which makes the 42.31% quarterly gain here even more notable.
For a retail investor studying this data, the smaller stock count in the recently bought and sold lists (positions changing by just 1 to 2 percentage points) is a reminder that even active investors managing large diversified portfolios often make measured, incremental changes rather than dramatic all-in bets.
Should You Act on These Moves?
Before treating any single buy or sell here as a signal, remember that this portfolio is built on 42 individual decisions, each shaped by research, valuation views, and risk appetite that are not disclosed alongside the raw numbers.
Companies like WEP Solutions, Magnum Ventures, and Inter State Oil Carrier deserve independent research on their own fundamentals, not a decision based purely on the fact that they appeared in a recent buy list. Use this data to build a watchlist, not a ready-made trading plan.
It is also worth remembering that quarterly disclosure lag applies just as much to a 42 stock portfolio as it does to a two stock one. By the time this filing became public, several weeks or months may have passed since the actual trades happened. Market conditions, valuations, and even the investor’s own view on these companies could have shifted in that time, so treat the data as a historical record rather than a live feed of current thinking.
Summary
Dipak Kanayalal Shah holds a Rs 176.14 crore disclosed portfolio spread across 42 stocks, up 42.31% for the quarter. Pharmaceuticals, commercial services, and consumer durables lead the sector mix, with Borosil, Kilitch Drugs India, and Amrutanjan Health Care as the top three holdings. Recent activity shows modest buying in WEP Solutions, Magnum Ventures, and Inter State Oil Carrier, alongside small trims in Organic Coatings and Jaipan Industries.
FAQs
How much is Dipak Kanayalal Shah’s disclosed portfolio worth?
It stands at Rs 176.14 crore as per the latest Superstar Portfolio filing, up 42.31% from the previous quarter.
What is the largest holding in this portfolio?
Borosil is the top disclosed holding at Rs 27.07 crore, followed by Kilitch Drugs India and Amrutanjan Health Care.
Is this a concentrated or diversified portfolio?
With 42 disclosed stocks and no single holding making up more than about 15% of total value, this leans strongly toward a diversified investing style.
What stocks were recently added to the portfolio?
Recent buys include WEP Solutions, Magnum Ventures, and Inter State Oil Carrier, each seeing modest increases in portfolio weight.
Why did the portfolio value rise 42% this quarter?
The increase could reflect rising stock prices, fresh buying, or both. Superstar Portfolio disclosures do not separate these two factors.
Key Takeaways
- The disclosed portfolio is worth Rs 176.14 crore, up 42.31% quarter on quarter.
- It spans 42 stocks, reflecting a diversified, small and mid cap focused style.
- Pharmaceuticals & Biotechnology leads the sector mix at 22.32%.
- Borosil, Kilitch Drugs India, and Amrutanjan Health Care are the top three holdings.
- Recent buys favored WEP Solutions, Magnum Ventures, and Inter State Oil Carrier.
- Organic Coatings and Jaipan Industries saw small reductions in weight.
- No single stock dominates, so portfolio performance likely depends on many smaller moves adding up.
